Please read and agree to the
terms and conditions
of this site.
I agree
Medical Technology
/tech
Clear filters and search
Format
photo
Tags
boston blog main
boston top stories
3
×
life sciences
national blog main
national top stories
new york blog main
new york top stories
san francisco blog main
san francisco top stories
amgen
biotech
boulder/denver blog main
boulder/denver top stories
detroit blog main
detroit top stories
eli lilly
gene editing
national
raleigh-durham blog main
raleigh-durham top stories
san diego blog main
san diego top stories
seattle blog main
seattle top stories
texas blog main
texas top stories
vertex pharmaceuticals
wisconsin blog main
wisconsin top stories
abbvie
advaxis
aimmune therapeutics
alder biopharmaceuticals
alexander hardy
allergan aesthetics
alzheimer's disease
andrew oxtoby
astrazeneca
athira pharma
attralus
What
ceo
3
×
week
3
×
big
bio
drug
medicine
moves
roundup
aces
acquisitions
announced
biggest
bosley's
bosley’s
bridge
bucks
build
buy
cas
cholesterol
company’s
crime
crispr
daniel
debut
departure
dyne’s
editas
exit
flexible
gilead
guiding
inclisiran
katrine
key
lowering
meant
medco
medicines
microbiome
Language
unset
Current search:
ceo
×
" boston top stories "
×
week
×
@xconomy.com
3 years ago
Bio Roundup: SeaGen Scores, Dyne’s Debut, Microbiome Moves & More
@xconomy.com
4 years ago
As Cholesterol Drug Aces Big Test, MedCo CEO Open to Flexible Pricing
@xconomy.com
5 years ago
Bio Roundup: Bosley’s Editas Exit, Bridge Bucks, CRISPR Crime & More